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 20 
Highlights 21 
 Circulation of avian HEV was determined in healthy commercial layer farms in the 22 
United States.  23 
 A fluorescent microbead immunoassay (FMIA) was developed for detecting anti-avian 24 
HEV IgY antibodies. 25 
 Prevalence of avian HEV infection was high among clinically healthy laying hens. 26 
 Different avian HEV genotype 2 strains were circulating within a farm. 27 
 28 
Abstract 29 
The objective of this study was to determine patterns of avian HEV infection in 30 
naturally infected chicken farms. A total of 310 serum samples and 62 pooled fecal samples 31 
were collected from 62 chicken flocks on seven commercial in-line egg farms in the 32 
Midwestern United States and tested for avian HEV circulation. Serum samples were tested 33 
for presence of anti-avian HEV IgY antibodies by a fluorescent microbead immunoassay 34 
(FMIA) which was developed for this study. The FMIA was validated using archived 35 
samples of chickens with known exposure (n = 96) and compared to the result obtained with 36 
an enzyme-linked immunosorbent assay (ELISA) based on the same capture antigen. There 37 
was an overall substantial agreement between the two assays (κ = 0.63) with earlier detection 38 
of positive chickens by the FMIA (P = 0.04). On the seven farms investigated, the overall 39 
prevalence of anti-avian HEV IgY antibodies in serum samples from commercial chickens 40 
was 44.8% (20-82% per farm). Fecal samples were tested for avian HEV RNA by a nested 41 
reverse-transcriptase PCR. The overall detection rate of avian HEV RNA in fecal samples 42 
was 62.9% (0-100% per farm). Sequencing analyses of partial helicase and capsid genes 43 
showed that different avian HEV genotype 2 strains were circulating within a farm. However, 44 
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no correlation was found between avian HEV RNA detection and egg production, egg weight 45 
or mortality. In conclusion, avian HEV infection is widespread among clinically healthy 46 
laying hens in the United States.  47 
 48 
Keywords: Avian hepatitis E virus (avian HEV); Chickens; Fluorescent microsphere 49 
immunoassay, RT-PCR, Subclinical infection.  50 
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Introduction 51 
Hepatitis E virus (HEV) are non-enveloped, single-stranded RNA viruses with an 52 
icosahedral capsid symmetry that belongs to the family Hepeviridae (Meng et al., 2012). 53 
HEV has been identified in several animal species (Meng, 2013) and, based on host tropism 54 
and genetic relatedness, strains genetically characterized thus far can be classified into two 55 
genera: genus Orthohepevirus (all mammalian and avian hepatitis E virus [avian HEV] 56 
isolates) and genus Piscihepevirus (cutthroat trout virus) (Smith et al., 2014). Currently, four 57 
avian HEV genotypes have been described in chicken flocks worldwide (Johne et al., 2014). 58 
Genotype 1 has been identified in Australia and Korea, genotype 2 is present in North 59 
America, genotype 3 is present in Europe and China and, more recently, a novel putative 60 
genotype 4 has been detected in Hungary and Taiwan (Marek et al., 2010; Banyai et al., 61 
2012; Kwon et al., 2012; Hsu and Tsai, 2014a). The avian HEV genome contains three open 62 
reading frames (ORFs): ORF1 encodes non-structural viral proteins, ORF2 encodes the 63 
capsid protein and ORF3 encodes a small multifunctional phosphoprotein (Meng et al., 64 
2012). 65 
 66 
A HEV-related sequence was first detected in chickens with big liver and spleen 67 
disease in Australia (Payne et al., 1999). A similar disease manifestation, designated as 68 
hepatitis-splenomegaly syndrome (HSS), was first associated with avian HEV in North 69 
America (Haqshenas et al., 2001). In both broiler breeder hens and egg-type chickens ranging 70 
from 30 to 72 weeks of ages, HSS is clinically characterized by increased mortality and 71 
decreased egg production. On gross examination, blood-tinged fluid can frequently be 72 
observed in the coelomic cavity and livers and spleens are typically both enlarged (Meng and 73 
Shivaprasad, 2013). A significant proportion of chicken flocks worldwide are seropositive to 74 
avian HEV, even though seropositive flocks do not necessarily suffer from HSS (Meng and 75 
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Shivaprasad, 2013). Thus far, no clear association between avian HEV strains and 76 
pathogenicity has been established (Marek et al., 2010). Avian HEV isolates obtained from 77 
healthy chickens were able to induce liver lesions but did not produce clinical HSS in 78 
specific-pathogenic-free chickens (Billam et al., 2009). However, apparently healthy 79 
chickens with reduced egg production have been shown to be positive for avian HEV RNA in 80 
the absence of other pathogens, suggesting that subclinical infection with avian HEV may 81 
impair egg production in broiler breeders (Sprygin et al., 2012). Therefore, additional studies 82 
are needed to elucidate the significance of avian HEV infections in clinically healthy laying 83 
hens. 84 
 85 
Current methods to demonstrate avian HEV infection include conventional and real-86 
time reverse transcriptase (RT) PCR assays for detection of avian HEV RNA (Sun et al., 87 
2004; Bilic et al., 2009; Troxler et al., 2011) and commercial and in-house enzyme-linked 88 
immunosorbent assays (ELISA) and agar gel immunodiffusion (AGID) tests for detection of 89 
anti-avian HEV antibodies (Huang et al., 2002; Morrow et al., 2008; Zhao et al., 2013; Hsu 90 
and Tsai, 2014b). ELISAs based on the ORF2 capsid protein have been widely adapted and 91 
are commonly used in serological surveys (Peralta et al., 2009; Kwon et al., 2012; Zhao et al., 92 
2013; Liu et al., 2014). Fluorescent microbead immunoassays (FMIA) are increasingly being 93 
used in veterinary serology (Wagner et al., 2011; Langenhorst et al., 2012; Gimenez-Lirola et 94 
al., 2014). An advantage of this new technology is the ability to screen for antibodies against 95 
multiple pathogens simultaneously in one reaction well using a small amount of sample, thus 96 
saving time, labor and reagents. In addition, FMIAs may have improved sensitivity compared 97 
to conventional serological assays, such as ELISAs (van Gageldonk et al., 2008).  98 
 99 
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The objective of this study was to evaluate the avian HEV infection dynamics, 100 
including fecal avian HEV RNA shedding and prevalence of anti-avian HEV antibodies, in 101 
healthy layer hen flocks in the Midwestern United States. For serology purposes, an FMIA to 102 
detect anti-avian HEV IgY antibodies was developed, validated and compared with an 103 
indirect ELISA.  104 
 105 
Material and methods 106 
Farm selection and characterization  107 
Seven commercial egg farms, designated A through G, volunteered to participate in 108 
this study. The final number of participating farms was determined based on responses to an 109 
email sent to the farms’ managers and/or veterinarian-in-charge, and to on-farm availability 110 
to provide the specified samples and production data. Participating farms were located in four 111 
U.S. Midwestern states: Iowa, Illinois, Michigan and South Dakota. At the time of sample 112 
collection Iowa represented the largest U.S. egg producer and Michigan was ranked seventh. 113 
The number of sampled farms did not reflect the state’s egg production. Each farm had an 114 
egg production facility wherein eggs were collected from multiple chicken houses and 115 
transported to an egg processing room via a collection of belts and conveyors. These in-line 116 
operations produced washed and graded whole shell eggs for retail and/or food service 117 
customers. Chickens on each farm were vaccinated against Marek’s disease, infectious 118 
bronchitis, Newcastle disease, avian influenza, fowl pox, Mycoplasma gallisepticum, and 119 
Salmonella Enteritidis.  120 
 121 
Samples were collected between October and December 2013. At the time of sample 122 
collection, chickens in flocks on participating farms were healthy and none had clinical signs 123 
associated with HSS. A flock consisted of all chickens housed in one building.  All flocks on 124 
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each farm were sampled (n = 5 to 11, average n = 8). Production data available for each flock 125 
included average hen-day egg production (%), weekly mortality (%), and egg weight.  126 
 127 
Sample collection  128 
A total of 310 serum samples were collected from 62 flocks divided among seven egg 129 
farms. From each flock, blood samples were taken from each of five chickens arbitrarily 130 
selected from different locations within a house. Blood samples were acquired by 131 
venipuncture of the brachial vein in 5 ml serum tubes (n = 25 to 55/farm; average n = 42). In 132 
addition, one pooled fecal sample was obtained from each house by collecting and pooling 2 133 
g of fresh droppings from manure pits at five arbitrarily selected sites.  134 
 135 
Blood and fecal samples were collected on the same day from all flocks on a farm, 136 
labeled with the house number, placed in insulated boxes with ice packs (4 °C) and shipped 137 
on the day of collection to the Iowa State University Veterinary Diagnostic Laboratory (ISU-138 
VDL), Ames, Iowa. Upon arrival, blood was centrifuged at 1500 ×g for 10 min to harvest 139 
serum and aliquotted into 4 mL plastic tubes. Fecal samples were homogenized and an 140 
aliquot of 0.4 g was resuspended in 4 ml PBS, vigorously vortexed, and centrifuged at 1500 141 
×g for 10 min. All samples were stored at −80 °C until testing. Shipping and storage 142 
conditions were similar for all samples.  143 
 144 
Fluorescent microbead immunoassay (FMIA) development 145 
Experimental serum samples 146 
Ninety-six serum samples from 36 specific-pathogen-free chickens from a previous avian 147 
HEV study (Billam et al., 2009) were used as positive and negative controls to develop the 148 
FMIA. Briefly, 24 6-week-old chickens were intravenously inoculated with avian HEV 149 
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genotype 2. Blood samples were collected before inoculation and weekly thereafter for a total 150 
of four weeks. Twelve chickens where sham-inoculated and served as negative controls. 151 
Seroconversion started at day post-inoculation (dpi) 14 and at dpi 28 all inoculated chickens 152 
had seroconverted to avian HEV as previously determined by an in-house ELISA (Billam et 153 
al., 2009). A total of 36 negative control samples (all samples collected on dpi 0) and 60 154 
samples (dpi 7–28) from chickens infected experimentally were tested. Specifically, negative 155 
control samples were used for estimating diagnostic specificity and 24 serum samples from 156 
experimentally infected chickens collected on dpi 21 (n = 12) or 28 (n = 12) were used for 157 
estimating diagnostic sensitivity of the FMIA.  158 
 159 
Antigen and conjugation to carboxylated paramagnetic microbeads 160 
A truncated recombinant ORF2 capsid protein of avian HEV expressed in Escherichia 161 
coli and purified by affinity chromatography as described previously (Haqshenas et al., 2002) 162 
was used as antigen for the FMIA. Fluorescent microsphere coupling was performed using a 163 
method described previously (Gimenez-Lirola et al., 2012) by addition of 25 μg of the avian 164 
HEV recombinant ORF2 capsid protein to 2.5 × 10
6 
carboxylated-fluorescent microbeads 165 
(bead region 64, Luminex Corp., Austin, TX, USA). 166 
 167 
FMIA 168 
The assay was performed as described previously (Gimenez-Lirola et al., 2012) with 169 
exception that a 1:2000 dilution of a biotin-conjugated goat anti-chicken IgY Fc (Gallus 170 
Immunotech) was used. Samples were analyzed using a Luminex-100 flow cytometer 171 
(Luminex) at default settings set by the manufacturer. Median fluorescence intensity (MFI) of 172 
the reporter signal estimated from 50 beads was used for the data analysis. A set of internal 173 
standard controls described as high positive control, low negative control and cut off control, 174 
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were selected after initial analysis and subsequently included on each plate. Additionally, a 175 
blank control (serum diluent) was included on each plate. The MFI data was corrected for 176 
background levels by subtracting the blank control MFI from the sample MFI (MFI-177 
Bkg). Results were presented as antibody index (MFI-Bkg sample/MFI-Bkg cut off serum). 178 
Samples with an index value below 0.9 were considered negative and those above 1.1 were 179 
considered positive. Values from 0.9 to 1.1 were considered inconclusive. 180 
 181 
Cut-off value determination 182 
Sensitivity and specificity were evaluated using receiver operator characteristic (ROC) curve 183 
analysis. The optimal cut-off points determined to be a sample MFI value ranging between 184 
1008 and 1297 giving an overall diagnostic sensitivity and specificity of 100%. The 185 
cumulative area under the ROC curve (AUC) indicated that the aHEV ORF2-based FMIA 186 
was 100% accurate. The analysis was performed using GraphPad Prism v. 6.01 (GraphPad 187 
Software). 188 
 189 
Assay reproducibility 190 
The reproducibility of the FMIA was evaluated by utilizing six different chicken sera. The 191 
coefficient of variation (CV) was used to evaluate the intra- and inter-assay variation. The 192 
inter-assay CV determined by each sample tested in three different runs on different 193 
occasions ranged from 0.57% to 7.83%; while the intra-assay CV determined by three 194 
replicates tested within the same run ranged from 0.74% to 7.99%, indicating that the results 195 
were reproducible. 196 
 197 
Comparison of FMIA and ELISA  198 
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 In order to evaluate the FMIA, a subset of the experimental (n = 48) and the field (n 199 
= 56) serum samples were tested for the presence of specific anti-avian HEV IgY antibodies 200 
by an in-house ELISA described elsewhere (Billam et al., 2009) using the same antigen used 201 
in this study. For comparison, the results were presented as an antibody index as specified for 202 
the FMIA test (sample OD or MFI-Bkg/cut off serum mean OD or MFI-Bkg).  203 
 204 
RNA extraction and avian HEV RNA detection 205 
RNA extractions from the fecal samples were performed using the QIAamp Viral 206 
RNA Mini kit (Qiagen). Extracts were subsequently used for detection of the partial helicase 207 
and capsid genes of avian HEV as described previously (Sun et al., 2004) in nested RT-PCR 208 
reactions. Briefly, for the helicase gene detection, external primer set 5′-209 
TGTTATYACACCCACCAARACGYTG-3′, and 5′-CCTCRTGGACCGTWATCGACCC-210 
3′; and internal primer set 5′-GCCACGGCTRTTACACCYCAYGT-3′, and 5′-211 
GACCCRGGRTTCGACTGCTT-3′ were used. For the capsid gene, external primer set 5′- 212 
TCGCCYGGTAAYACWAATGC-3′, and 5′-GCGTTSCCSACAGGYCGGCC-3′; and 213 
internal primer set 5′- ACWAATGCYAGGGTCACCCG -3′, and 5′- 214 
ATGTACTGRCCRCTSGCCGC -3′ were used. PCR products were examined on a 1% 215 
agarose gel and amplicons with the expected size (386 bp for the helicase gene and 242 bp 216 
for the capsid gene) were excised and purified with the QIAquick Gel Extraction Kit 217 
(Qiagen).  218 
 219 
Sequencing and phylogenetic analyses 220 
Sequencing of at least two avian HEV capsid and two helicase RT-PCR positive 221 
samples from each farm was performed directly on both strands at the Iowa State University 222 
DNA Facility, Ames, Iowa, USA (Applied Biosystems 3730xl DNA Analyzer). Sequences 223 
Page 10 of 26
11 
 
were aligned with published data using BLAST at the national Centre for Biotechnology 224 
Information (NCBI)
1
. Sequences were compiled using Lasergene software and the Clustal V 225 
alignment algorithm (DNAStar). Identical nucleotide sequences were represented as one 226 
sequence and used in phylogenetic analysis. For sequence analysis, the 361 bp sequences of 227 
the helicase gene and 232 bp of the capsid gene were compared to each other and to 228 
sequences of other avian HEV isolates representing genotypes 1 (GenBank accession 229 
numbers AM943647and JN597006), 2 (GenBank accession numbers AY535004, EF206691, 230 
and EU919187), 3 (GenBank accession numbers AM943646 and GU954430), and 4 231 
(GenBank accession numbers JN997392 and KF511797). Sequences reported herein were 232 
deposited in the GenBank database under the accession numbers KJ495790 to KJ495804 and 233 
KJ914879 to KJ914889.      234 
 235 
Statistical analysis  236 
Summary statistics including normality were calculated for all the farms. For each 237 
flock actual egg production, mortality and egg weights were compared to the breed standards. 238 
Breed standard values were defined and provided by the genetic companies for each week of 239 
the egg chicken production cycle for the specific genetic line utilized and were valid for the 240 
year in which samples were collected. Breed standards are publically shared by all genetic 241 
companies and are applicable for any commercial farm located in the U.S. Statistical analysis 242 
of the data among farms was performed by one-way analysis of variance (ANOVA). 243 
Pearson’s correlation test was used to correlate presence of avian HEV RNA in feces with 244 
egg production, egg weight, and hen mortality. A kappa index (κ) was performed to 245 
determine the agreement of positive and negative results between ELISA and FMIA. The 246 
strength of agreement was scored as follows: ≤0, poor; 0.01 to 0.2, slight; 0.21 to 0.4, fair; 247 
                                                 
1
 http://www.ncbi.nlm.nih.gov 
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0.41 to 0.60, moderate; 0.61 to 0.80, substantial; and 0.81 to 1, almost perfect. P  < 0.05 was 248 
set as the statistically significant level. The statistical analyses were performed using the SAS 249 
v.9.2 (SAS Institute). 250 
 251 
Results 252 
Evaluation and validation of the FMIA  253 
The earliest detection of avian HEV-specific IgY antibodies was detected at dpi 14 in 254 
29.2% (7/24) avian HEV infection. On dpi 21 and onwards all 24 chickens were positive for 255 
anti-avian HEV IgY antibodies. 256 
 257 
To further evaluate the avian HEV FMIA, the same antigen used in the FMIA was 258 
coated on 96-wells ELISA plates. Internal FMIA controls, 48 experimental serum samples, 259 
and 56 field serum samples were tested by the ELISA. There was a substantial agreement 260 
between ELISA and FMIA when using the ORF2 recombinant capsid antigen (κ = 0.63). 261 
Although there was no difference for the overall detection rates between assays (43.4% 262 
[53/122] FMIA vs. 36.0% [44/122] ELISA; P = 0.052), when considering only the 263 
experimental samples subset, FMIA showed a higher detection rate at 14 dpi (7/12 vs. 1/12, P 264 
= 0.04) (Table 1). 265 
 266 
Production data 267 
Egg production, mortality and egg weights were compared to breed standards. 268 
Average egg production and average mortality data for participating flocks on each of the 269 
seven investigated farms are shown in Fig. 1. A summary of median, maximum and 270 
minimum mortality, egg production and egg weights for each farm are shown in Fig. 2.  271 
 272 
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Overall performance of all farms at the time of sample collection was satisfactory and 273 
mortality rates were mostly within an acceptable range when compared to breed standards 274 
(average ± SD, 0.13 ± 0.06) with exception of Farm B that presented an average 10% 275 
increase in mortality rates (P < 0.05) (Fig. 2). Maximum reported weekly mortality was 276 
0.27% at 87 weeks of age on Farm B, 0.27% at 81 weeks of age on Farm E, and 0.27% at 109 277 
weeks of age on Farm G (Fig. 1).  278 
 279 
Egg production met or exceeded standard egg production curves in 5 of 7 farms (Figs. 280 
1 and 2). Specifically, egg production on Farms A and B was on average 4 to 7% lower when 281 
compared to the breed standards while Farm C presented on average a 3.5% higher egg 282 
production (P < 0.05) (Fig. 2). On Farm A, egg production in 92 to 97 week old flocks was 283 
on average 11% less than expected and on Farm B, egg production decrease was on average 284 
18% from 87 to 94 weeks of age (Fig. 1). On Farm D, there was a 12% drop in egg 285 
production in the 89 week old flock; however the overall egg production was on average 5% 286 
higher than the breed standard in the other flocks (Fig. 1). Lack of egg production from hens 287 
on Farm B at 77 weeks of age and on Farm G at 76 weeks of age was due to induction of 288 
molt prior to onset of a second production cycle, a routine procedure used by commercial egg 289 
producers in the Midwestern United States.  290 
 291 
Egg weights were within an acceptable range when compared to breed standards with 292 
exception of a flock in Farm G had a maximum decrease of 10.09% when compared to the 293 
standard (Fig. 2). In all other flocks the maximum egg weight decrease was lower than 5.00% 294 
(average ± SD, 0.97 ± 2.67) with exception of Farm F that exceed the breed standards (Fig. 295 
2).  296 
 297 
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Detection of anti-avian HEV IgY antibodies  298 
The detection rates of anti-avian HEV IgY antibodies are shown in Fig. 1 and Table 2. 299 
All seven investigated chicken farms had at least one seropositive animal. Considering all 300 
farms, the overall detection rate of anti-avian HEV IgY antibodies was 44.8% (145/310). The 301 
proportion of positive animals ranged from 20% (5/25, Farm F) to 82.0% (41/50, Farm B) per 302 
farm. Considering all the examined animals by rank of age, seropositive animals were 303 
detected at any age, but chickens older than 50 weeks were found to have higher 304 
seropositivity rates compared to 16-26 and 31-45 weeks old chickens (P < 0.05).  305 
 306 
Detection of avian HEV RNA and correlation with production data 307 
The detection rates of avian HEV RNA are shown in Fig. 1 and Table 2.The overall 308 
detection rate of avian HEV RNA in the pooled fecal samples of the seven studied farms was 309 
62.9% (39/62) considering the combined results of both RT-PCR assays utilized (capsid 310 
gene, 32/62; helicase gene, 38/92). The majority of flocks (31/39) were RT-PCR positive for 311 
both capsid and helicase genes. However; on Farm B, the 69 week old flock was only 312 
positive for the capsid gene, and the 91week old flock was only positive for the helicase 313 
gene. On Farm C, the flocks with layer hens at 16, 23, 23, 43, 94 and 103 weeks of age were 314 
positive only for the helicase gene. 315 
     316 
All tested samples from Farms E (n = 7) and F (n = 5) were negative for avian HEV 317 
RNA which coincided with the lowest detection of anti-avian HEV IgY antibodies among all 318 
tested farms, 22.9% and 20%, respectively (Table 2). Avian HEV RNA was detected in 40% 319 
(4/10) of the samples on Farm G and in 75-100% of the samples on Farms A, B, C, and D 320 
(Table 2). No correlation was found between avian HEV RNA detection and hen-day egg 321 
production (P = 0.09), weekly hen mortality (P = 0.37) or egg weight (P = 0.15). 322 
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 323 
Sequence and phylogenetic analyses 324 
At least two avian HEV RNA positive samples were selected for sequencing of both a 325 
361 bp region in the helicase gene and a 232 bp region of capsid gene in each farm. The 326 
sequences obtained were compared with the reference strains of each avian HEV genotype. 327 
All sequences clustered within avian HEV genotype 2 previously identified in the USA (Fig. 328 
3).  329 
 330 
Sequence analysis of the helicase gene from Farms A to G presented 82.3- 99.7% of 331 
nucleotide sequence identity. Within a farm, nucleotide sequence identities varied from 85.2-332 
99.7%. Between sequences described here and the USA prototype avian HEV, the nucleotide 333 
sequence identify was 84.9-88.6% and it was 84.9-97.2% to the avirulent avian HEV-VA 334 
strain. Sequence identities with avian HEV genotype 1, 3 and 4 isolates varied between 76.5-335 
82.5%.  336 
 337 
Sequence analysis based on the capsid gene revealed similar results. Among farms, 338 
nucleotide sequence identity of avian HEV strains varied between 80.6-97.0%. Within a 339 
farm, nucleotide sequence identities varied from 85.2-97.3%. Between sequences described 340 
here and the USA prototype avian HEV and avirulent avian HEV-VA strains, there was 85.1-341 
88.9% and 79.7-90.1% nucleotide sequence identity, respectively. Sequence identities with 342 
avian HEV genotype 1, 3 and 4 isolates varied between 73.8-77.9%. 343 
 344 
Discussion 345 
Serological surveys have shown a worldwide distribution of avian HEV infection, 346 
although clinical cases of HSS seem to occur infrequently (Meng and Shivaprasad, 2013). 347 
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Often avian HEV is considered as minor causative agent in diagnostic investigations but is 348 
frequently regarded as insignificant when another poultry disease has been diagnosed in the 349 
same chickens. However, drops in egg production and increased mortality have been reported 350 
in clinically healthy chickens infected with avian HEV in the absence of other known 351 
pathogens (Sprygin et al., 2012). To further investigate the patterns of avian HEV infection in 352 
apparently healthy chickens, fecal samples were tested for HEV RNA by RT-PCR and serum 353 
samples were tested for anti-avian HEV IgY antibodies by FMIA. In addition, mortality rates 354 
and egg production, parameters usually affected during HSS outbreaks, and egg weight as 355 
indirect method to evaluate the liver function (Husbands, 1970), were acquired from the 356 
flocks. Egg weight is largely determined by yolk weight (Jaffe, 1964), and yolk is 357 
synthesized in the liver hepatocytes.  358 
 359 
Although Farm B, which presented the highest detection rates of avian HEV, showed 360 
the overall highest increase in mortality and highest decrease in egg production within the 361 
farms sampled, no associations between egg production data, mortality rates and detection 362 
rates of avian HEV RNA were found when using the cumulative data of all farms. Different 363 
management factors and biosecurity measures of each farm, diet, host genetics and presence 364 
of other pathogens could partially explain differences between production performances 365 
among flocks (Gerber et al., 2014). In fact, a prospective study has found that nearly identical 366 
avian HEV nucleotide sequences have been retrieved from broiler breeder flocks over two 367 
years, independent of clinical signs (Troxler et al., 2014). In this same study, viral load did 368 
not seem to have an effect on pathogenicity (Troxler et al., 2014). Recently, a pilot study 369 
using experimentally infected broiler breeder chickens could reproduce more typical 370 
macroscopic and microscopic avian HEV lesions than previous studies with young chickens 371 
(Park et al., 2015). However, production losses commonly associated with avian HEV 372 
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outbreaks have not been reproduced experimentally to date. Further systemic prospective 373 
studies addressing avian HEV subclinical infection and its impact on production data on a 374 
larger scale are needed.  375 
 376 
Testing serum samples from chickens with unknown avian HEV exposure in this 377 
study indicated that the seropositive rate of anti-avian HEV IgY antibodies was 44.8% 378 
(145/310) in sexually mature chickens at various stages of egg production and that all farms 379 
studied were seropositive for anti-avian HEV IgY antibodies with a detection rate ranging 380 
from 20% to 82% per farm. This finding is in agreement with previous reports from the U.S. 381 
and other countries (Huang et al., 2002; Peralta et al., 2009; Kwon et al., 2012; Zhao et al., 382 
2013). The present study also suggests that the likelihood of being seropositive increases with 383 
age, as previously described (Huang et al., 2002; Peralta et al., 2009; Troxler et al., 2014). 384 
 385 
Avian HEV RNA was detected in five of the seven farms tested, including in hens 386 
close to the end of the egg production (> 100 weeks of age) and in farms with high numbers 387 
of avian HEV seropositive chickens. This suggests that the humoral response may not offer 388 
complete protection against avian HEV fecal shedding and/or that chickens might be re-389 
infected at different points of the production cycle with different strains of avian HEV. 390 
Indeed, sequencing of avian HEV partial helicase and capsid genes showed that different 391 
strains of avian HEV existed on the same farm. Similarly, HEV re-infection in seropositive 392 
animals has been reported in adult pigs (de Deus et al., 2008). Possible factors that could 393 
explain the co-circulation of different avian HEV sequences on a farm include co-mingling 394 
animals from different sources, a common food supplier or shared workers between different 395 
farms; however, these factors were not investigated in the present study. Although there is no 396 
currently available information regarding the cross-protection among different avian HEV 397 
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genotypes, vaccination of pigs with recombinant capsid antigens derived from HEV isolated 398 
from swine, rat, and avian induced a strong IgG anti-HEV antibody response but only a 399 
partial cross-protection to a HEV genotype 3 challenge (Sanford et al., 2012).  400 
 401 
Interestingly, avian HEV RNA was not detected in any of the flocks in Farms E and F 402 
although anti-avian HEV antibodies were detected in most of the flocks on all farms 403 
investigated. The failure in detecting avian HEV genome could be due to a lower amount of 404 
viral shedding into the fecal material of chickens without clinical signs. As pooled samples 405 
were used for the analysis, the dilution effect could have decreased the viral copies below the 406 
detection limit of the assay used. Alternatively as the avian HEV genome shows a high 407 
variability (Sprygin et al., 2012), the primers used for avian HEV RNA detection in the 408 
present study may have not amplified the viral genome due to mismatches in the sequences. 409 
In addition, lack of detection could be due to poor quality of samples and possible 410 
degradation of viral RNA, although samples from all farms were processed and tested 411 
similarly. It is also worth noting that Farms E and F contained the lowest number of flocks 412 
among the farms sampled in the present study which could have decreased the chances of 413 
detecting positive samples if the viral shedding was low. A higher number of fresh fecal 414 
samples from each flock should be tested to address these issues. 415 
  416 
In conclusion, avian HEV infection was detected directly (RNA) or indirectly 417 
(antibodies) in all studied U.S. farms. Different strains of avian HEV genotype 2 were found 418 
in different flocks within a farm. There was no clear association between levels of egg 419 
production or mortality and detection rates of avian HEV RNA.   420 
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Figure legends 553 
 554 
Fig. 1. Actual and standard egg production (%), actual and standard weekly mortality (%), 555 
anti-avian HEV IgY antibodies detection rate by FMIA (%) (grey bars) and avian HEV RNA 556 
detection by nested RT-PCR (red boxes indicate the age group that was found positive for 557 
HEV RNA) for flocks on Farm A (n=11 flocks), Farm B (n=10 flocks), Farm C (n= 11 558 
flocks), Farm D (n= 8 flocks), Farm E (n= 7 flocks), Farm F (n= 5 flocks) and Farm G (n= 10 559 
flocks).  560 
 561 
Fig. 2. Difference (%) of actual mortality (A), egg production (B), and egg weights (C) in 562 
Farms A through G when compared to the breed standards. The box-and-whiskers plots show 563 
cumulative results of all flocks within a farm. Different superscripts (a,b) indicate significant 564 
(P < 0.05) differences between farms for the measured parameter.  565 
 566 
Fig. 3. Phylogenetic tree based on 361 bp of the helicase gene (A) and 232 bp of the capsid 567 
gene (B) of the avian HEV isolates. Sequences that were obtained in this study are indicated 568 
in a black box. The phylogenetic tree was constructed by the NJ method implemented in the 569 
Lasergene software (DNASTAR). The nucleotide substitution per 100 residues is given; 570 
bootstrap values are indicated for the major nodes. Genotype classification represented as 571 
proposed by Marek et al. (2010) and Hsu and Tsai (2014).  572 
  573 
Page 23 of 26
24 
 
Table 1 574 
Comparison of anti-avian HEV antibodies detection rates with ELISA and FMIA on samples 575 
obtained from 12 experimentally infected chickens on different days post infection.  Data 576 
presented as number of positive chickens/total number of chickens tested (mean group 577 
antibody index ± standard deviation). 578 
Assay 0 7 14 21 
FMIA 0/12 (0.04±0.07) 0/12  (0.03±0.02) 7/12  (2.62±3.08)
A*
 12/12 (6.87±3.17) 
ELISA 0/12  (0.20±0.04) 0/12  (0.23±0.08) 1/12  (0.41±0.32)
B
 9/12  (1.89±0.93) 
*
 Different superscripts (
A,B
) within a column indicate significant differences in detection (P < 579 
0.05) within groups. 580 
 581 
 582 
  583 
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Table 2  584 
Detection rates of anti-avian HEV IgY antibodies in serum samples tested by FMIA and 585 
avian HEV RNA in fecal samples tested by RT-PCR from Farms A through G. Data 586 
presented as number of positive samples/total number of samples tested (prevalence).  587 
 Farm 
Anti-avian HEV IgY 
antibody (%) 
Avian HEV RNA 
(%) 
A 29/55 (52.7)
B*
 10/11 (90.9)
B
 
B 41/50 (82.0)
C
 10/10 (100)
B
 
C 18/55 (32.7)
AB
 9/11 (81.8)
B
 
D 24/40 (60.0)
BC
 6/8 (75.0)
 B
 
E 8/35 (22.9)
A
 0/7
A
 
F 5/25 (20.0)
A
 0/5
A
 
G 36/50 (72.0)
BC
 4/10 (40.0)
B
 
*
Different superscripts (
A,B,C
) within a column indicate significant differences in detection 588 
rates (P < 0.05) among groups. 589 
 590 
591 
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